Linearis Joins Two Canadian AI Health Data Projects
Linearis was selected for two projects under the Terry Fox Research Institute Digital Health Innovation Fund, the company said in a press release. The fund is investing a combined $40.9 million in 14 Canadian projects involving 55 partners.
The first project will combine genomic, proteomic, and metabolomic data with AI to predict treatments for people with lung, breast, or colorectal cancer. Partners include MRM Proteomics, Simmunome, the Jewish General Hospital, and Nova Scotia Health.
The second project, conducted with Nanil Therapeutics, will use standardized health data and AI to identify biomarkers for studying and monitoring neurodegenerative diseases. Both projects will use federated learning infrastructure that supports analysis across institutions without transferring the underlying data.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 1 Midstream Health Raises $20M to Recover Hospital Payments Oct 31 AI Agent Controls Brain Injection in Live Mouse After Claude Opus Refuses Oct 31 Patient Sues Allegheny Health Network and Highmark Over Abridge AI Recordings Oct 31 OpenAI Releases GPT-Rosalind-6 for Approved Biology Researchers Oct 30 Surveys Find Widespread AI Chatbot Use Among Teens and TweensLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
INmune Bio and QCi Apply Quantum Computing to XPro Research
AstraZeneca and Oracle Partner on AI for Clinical Trials
Boehringer Ingelheim and Microsoft to Study Digital Patient Twins
Lunit and Discovery Life Sciences Partner on AI Tissue Analysis
Google.org Awards $36 Million to 17 AI Science Projects
Daily AI Brief: the AI news that matters, in your inbox.